ClinicalTrials.govpublic full text
Low-dose Trifluridine/Tipiracil With Bevacizumab in mCRC
colo-rectal cancer, third-line and beyond therapy, tas 102, bevacizumab, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 836763
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.